Company
Headquarters: Beijing, China
Employees: 282
CN¥2.82 Billion
CNY as of Jan. 1, 2026
US$402.6 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Its products include coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers, and platelet aggregation analyzers. The company was founded in 2003 and is headquartered in Beijing, China.
Beijing Succeeder Technology, Inc. has the following listings and related stock indices.
Stock: SSE: 688338